The other four genes, COCH, CST9, SOX11, and TDGF1, as well as CHST4, have also been implicated in the immune-related GO term, indicating the importance of immunomodulatory mechanisms in cancer therapy [27]. This evidence concerns the gene SOX11 and cancer.